Investors seem to view the decision to review Eastman Kodak's (EK +8.8%) patent dispute with...

|By:, SA News Editor

Investors seem to view the decision to review Eastman Kodak's (EK +8.8%) patent dispute with Apple (AAPL) and Research in Motion (RIMM) as a lifeline, but Cross Research remains skeptical of Kodak's long-term fundamentals, with "little confidence that any one-time payments would provide more than a short-term boost to the share price."